We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-21.62%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$74.1M
AUM Growth
-$20.3M
Cap. Flow
+$278K
Cap. Flow %
0.38%
Top 10 Hldgs %
97.63%
Holding
26
New
7
Increased
7
Reduced
3
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.8B
$64.5M 87%
1,059,118
+227
+0% +$16.4K
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$3.73M 5.03%
2,246,469
SRRA
3
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$938K 1.27%
+1,143
New +$1.29M
ACAS
4
DELISTED
American Capital Ltd
ACAS
$894K 1.21%
73,558
-2,876
-4% -$38.6K
IVTY
5
DELISTED
Invuity, Inc
IVTY
$475K 0.64%
33,905
GDX icon
6
CALL
VanEck Gold Miners ETF
GDX
$21.8B
$436K 0.59%
+31,733
New +$458K
NSL
7
DELISTED
NUVEEN SENIOR INCM FD
NSL
$417K 0.56%
70,518
+39,376
+126% +$244K
PHD
8
DELISTED
Pioneer Floating Rate Fund
PHD
$369K 0.5%
32,637
-4,000
-11% -$45.8K
SLRC icon
9
SLR Investment Corp
SLRC
$716M
$318K 0.43%
+20,098
New +$354K
EVF
10
Eaton Vance Senior Income Trust
EVF
$90.1M
$310K 0.42%
52,889
+3,429
+7% +$21.1K
FRA icon
11
BlackRock Floating Rate Income Strategies Fund
FRA
$380M
$309K 0.42%
23,888
+12,897
+117% +$170K
JRO
12
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$281K 0.38%
+28,207
New +$297K
MDLY
13
DELISTED
Medley Management Inc
MDLY
$233K 0.31%
3,526
+709
+25% +$61.9K
PFX icon
14
PhenixFIN
PFX
$88.7M
$216K 0.29%
1,454
-149
-9% -$25.4K
SCM icon
15
Stellus Capital Investment Corp
SCM
$220M
$213K 0.29%
+21,155
New +$228K
AGRX
16
DELISTED
Agile Therapeutics
AGRX
$155K 0.21%
12
+3
+33% +$53.3K
ICMB icon
17
Investcorp Credit Management BDC
ICMB
$12.3M
$150K 0.2%
+14,761
New +$173K
MDGL icon
18
CALL
Madrigal Pharmaceuticals
MDGL
$12.8B
$99K 0.13%
1,629
+143
+10% +$10.3K
OCSL icon
19
Oaktree Specialty Lending
OCSL
$1.07B
$98K 0.13%
+5,289
New +$102K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.06T
-1,511
Closed -$206K
GDX icon
21
VanEck Gold Miners ETF
GDX
$21.8B
-73,274
Closed -$1.06M
OXSQ icon
22
Oxford Square Capital
OXSQ
$153M
-31,142
Closed -$209K
ST icon
23
Sensata Technologies
ST
$6.55B
-10,853
Closed -$572K
VIRX
24
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-228
Closed -$144K
ESL
25
DELISTED
Esterline Technologies
ESL
-6,590
Closed -$628K

Similar funds

Caxton Corporation's Q3 2015 Portfolio in Review

As of Q3 2015, Caxton Corporation held 26 positions worth $74.1M, down 22% from $94.5M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation's Q3 2015 filing shows 7 new, 7 increased, 3 reduced and 7 closed positions. Its largest new stake was Sierra Oncology, Inc. Common Stock: 1,143 shares worth $938K. The largest sale was VanEck Gold Miners ETF, an estimated $1.06M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Financials and Technology.

  • Caxton Corporation's largest Q3 2015 buy was Sierra Oncology, Inc. Common Stock: 1,143 shares worth $938K.
  • Caxton Corporation added most to NUVEEN SENIOR INCM FD in Q3 2015, an estimated $244K increase.
  • Caxton Corporation's biggest Q3 2015 reduction was Pioneer Floating Rate Fund, cutting an estimated $45.8K.
  • Caxton Corporation fully exited VanEck Gold Miners ETF in Q3 2015, selling an estimated $1.06M.
  • Caxton Corporation's ten largest holdings make up 98% of its $74.1M portfolio in Q3 2015.
  • Caxton Corporation opened 7 new positions and closed 7 in Q3 2015.
  • Caxton Corporation's portfolio value fell 22% quarter-over-quarter to $74.1M.

Based on Caxton Corporation's 13F filing for Q3 2015, filed 16 Nov 2015.